Ruxolitinib for the Treatment of Myelofibrosis: A NICE Single Technology Appraisal Ros WadeMicah RoseNerys Woolacott Review Article 31 August 2013 Pages: 841 - 852
Using the Stated Preference Technique for Eliciting Valuations: The Role of the Payment Vehicle Dorte Gyrd-Hansen Review Article 06 September 2013 Pages: 853 - 861
The Road Not Taken: Transferability Issues in Multinational Trials Pepijn VemerMaureen P. M. H. Rutten-van Mölken Systematic Review 27 August 2013 Pages: 863 - 876
Patient Preferences for the Treatment of Type 2 Diabetes: A Scoping Review Susan M. JoyEmily LittleJohn F. P. Bridges Systematic Review 01 October 2013 Pages: 877 - 892
A Person Trade-Off Study to Estimate Age-Related Weights for Health Gains in Economic Evaluation Stavros PetrouNgianga-Bakwin KandalaRachel Baker Original Research Article 30 August 2013 Pages: 893 - 907
Cost-Effectiveness of Rivaroxaban Versus Warfarin for Stroke Prevention in Atrial Fibrillation in the Belgian Healthcare Setting Joris KleintjensXiao LiMimi De Ruyck Original Research Article Open access 13 September 2013 Pages: 909 - 918
Cost-Effectiveness Analysis of Triple Therapy with Protease Inhibitors in Treatment-Naive Hepatitis C Patients Antonio Blázquez-PérezRamón San MiguelJavier Mar Original Research Article 03 September 2013 Pages: 919 - 931
Projecting Expenditure on Medicines in the UK NHS Phill O’NeillJorge Mestre-FerrandizJon Sussex Original Research Article 14 September 2013 Pages: 933 - 957